LONDON — The U.K.'s FTSE 100 closed higher by a whisker to keep its winning streak intact and be on par with its best run in 2017. Most other European markets closed for the May 1 holiday.

Today’s best bluetooth earphones can actually give over-the-head headphones a run for their money on sound quality, says James Roth, Head of Consumer Electronics at TG0.

Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. Earlier this year, the Danish pharma traded barbs with telehealth provider Hims & Hers over the ...

Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers , Ro and LifeMD to sell Wegovy, as it looks to stem sales of copies of its popular weight-loss drug and expand access ...

My top pick for the best Bluetooth speaker is the Sonos Move 2. It might be a larger option, but it sounds incredible and packs in some epic battery life. It’s not cheap though, coming in at $ ...

Meanwhile, the Ultimate 2 Bluetooth will replace the original as GameSpot's pick for the best third-party Switch controller, and we're eager to see how it stacks up with the Switch 2 Pro Controller.

A bunch of first-party Nintendo accessories are launching alongside the Switch 2 on June 5, and the new Pro Controller figures to be one of the most popular picks. If you're one of the many Switch ...

Amazfit Active 2 has Bluetooth 5.2 and BLE connectivity Amazfit Active 2 has a Zepp Flow AI voice control feature It carries a 270mAh battery ...

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed a $2 billion deal to acquire the global rights to an experimental ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. What's the best Bluetooth speaker under $100? We're asked that question a lot, as buyers want ...

Novo reported Phase 1 data for an oral form of amycretin about a year ago. The new results involve a version of the drug delivered via an under-the-skin injection. They’re from a Phase 2 trial testing ...